PAUL STEVEN M
SEC CIK 1237564 · EDGAR
BoughtSold
Most active insiders at SPTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ARCH Venture Partners XII, LLC | 10% | $19.80M | — |
| 2 | HOMBACH ROBERT J. | Dir | $235.8K | — |
| 3 | Chen Michael Cunyuan | CSO | — | — |
| 4 | Gladstein Lana | GC | — | — |
| 5 | White Lauren | CFO | — | — |
| 6 | Torres Denice | Dir | — | — |
| 7 | Loebel Antony | Chief Medical Off | — | — |
| 8 | PureTech Health plc | 10% | — | — |
| 9 | HEALY JAMES | Dir | — | — |
| 10 | PAUL STEVEN M | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-04 18:05 | 2026-05-04 | SPTX | Seaport Therapeutics, Inc. | PAUL STEVEN M | Dir | C - Cnv Deriv | — | +67.0K | 863.0K | +8% | — |
| MI | 2025-09-15 | 2025-09-12 | RAPP | Rapport Therapeutics, Inc. | PAUL STEVEN M | Dir | P - Purchase | $24.65 | +41.7K | 41.7K | New | +$1.03M |
| D | 2022-04-05 | 2022-04-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PAUL STEVEN M | Dir | M - OptEx | $11.33 | +15.0K | 16.0K | +1,500% | +$169.9K |
| DM | 2022-04-05 | 2022-04-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PAUL STEVEN M | Dir | S - Sale+OE | $170.69 | -15.0K | 3,258 | -82% | -$2.56M |
Purchase Sale Sale after option exercise All abbreviations